Jeff Yass’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $318K | Buy |
90,899
+12,008
| +15% | +$45.5K | ﹤0.01% | 10912 |
|
|
2026
Q1 | $305K | Buy |
78,891
+13,709
| +21% | +$54K | ﹤0.01% | 10813 |
|
|
2025
Q4 | $256K | Buy |
65,182
+9,957
| +18% | +$44K | ﹤0.01% | 10312 |
|
|
2025
Q3 | $258K | Sell |
55,225
-32,623
| -37% | -$118K | ﹤0.01% | 10460 |
|
|
2025
Q2 | $273K | Buy |
87,848
+12,246
| +16% | +$39.5K | ﹤0.01% | 10555 |
|
|
2025
Q1 | $256K | Buy |
75,602
+13,903
| +23% | +$64.9K | ﹤0.01% | 10425 |
|
|
2024
Q4 | $350K | Buy |
61,699
+28,086
| +84% | +$181K | ﹤0.01% | 9496 |
|
|
2024
Q3 | $197K | Sell |
33,613
-23,153
| -41% | -$168K | ﹤0.01% | 10487 |
|
|
2024
Q2 | $449K | Buy |
56,766
+20,821
| +58% | +$175K | ﹤0.01% | 8520 |
|
|
2024
Q1 | $335K | Sell |
35,945
-11,214
| -24% | -$94.7K | ﹤0.01% | 9465 |
|
|
2023
Q4 | $398K | Sell |
47,159
-2,988
| -6% | -$21.7K | ﹤0.01% | 9193 |
|
|
2023
Q3 | $389K | Sell |
50,147
-16,719
| -25% | -$153K | ﹤0.01% | 8801 |
|
|
2023
Q2 | $766K | Sell |
66,866
-254,917
| -79% | -$2.64M | ﹤0.01% | 7308 |
|
|
2023
Q1 | $2.48M | Buy |
321,783
+182,684
| +131% | +$1.45M | ﹤0.01% | 4700 |
|
|
2022
Q4 | $849K | Buy |
139,099
+71,323
| +105% | +$405K | ﹤0.01% | 6543 |
|
|
2022
Q3 | $401K | Sell |
67,776
-28,177
| -29% | -$180K | ﹤0.01% | 9052 |
|
|
2022
Q2 | $567K | Buy |
+95,953
| New | +$648K | ﹤0.01% | 7954 |
|
|
2022
Q1 | – | Sell |
-39,992
| Closed | -$178K | – | 14082 |
|
|
2021
Q4 | $108K | Buy |
39,992
+16,324
| +69% | +$55.7K | ﹤0.01% | 12092 |
|
|
2021
Q3 | $62K | Sell |
23,668
-77,929
| -77% | -$253K | ﹤0.01% | 12276 |
|
|
2021
Q2 | $420K | Buy |
101,597
+55,301
| +119% | +$251K | ﹤0.01% | 10002 |
|
|
2021
Q1 | $218K | Buy |
46,296
+8,558
| +23% | +$58.4K | ﹤0.01% | 11253 |
|
|
2020
Q4 | $270K | Buy |
37,738
+16,356
| +76% | +$157K | ﹤0.01% | 9486 |
|
|
2020
Q3 | $228K | Sell |
21,382
-551
| -3% | -$6.47K | ﹤0.01% | 9250 |
|
|
2020
Q2 | $277K | Sell |
21,933
-16,710
| -43% | -$194K | ﹤0.01% | 8493 |
|
|
2020
Q1 | $354K | Buy |
38,643
+25,095
| +185% | +$288K | ﹤0.01% | 7660 |
|
|
2019
Q4 | $189K | Sell |
13,548
-4,052
| -23% | -$58.9K | ﹤0.01% | 8810 |
|
|
2019
Q3 | $303K | Sell |
17,600
-8,597
| -33% | -$180K | ﹤0.01% | 8282 |
|
|
2019
Q2 | $713K | Buy |
+26,197
| New | +$599K | ﹤0.01% | 6463 |
|
|
2019
Q1 | – | Sell |
-13,607
| Closed | -$177K | – | 9938 |
|
|
2018
Q4 | $128K | Buy |
+13,607
| New | +$175K | ﹤0.01% | 8087 |
|
|
2018
Q1 | – | Sell |
-36,276
| Closed | -$784K | – | 10275 |
|
|
2017
Q4 | $602K | Sell |
36,276
-6,921
| -16% | -$119K | ﹤0.01% | 6279 |
|
|
2017
Q3 | $889K | Buy |
+43,197
| New | +$487K | ﹤0.01% | 5483 |
|
|
2017
Q1 | – | Sell |
-18,705
| Closed | -$238K | – | 10073 |
|
|
2016
Q4 | $238K | Buy |
+18,705
| New | +$240K | ﹤0.01% | 8384 |
|
Other funds holding VYGR
AC
VPC
OM
Jeff Yass's VYGR Position: Q2 2026 in Review
Jeff Yass increased its Voyager Therapeutics (VYGR) stake by 15% in Q2 2026, buying an estimated $45.5K and bringing the position to 90,899 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #10912.
Jeff Yass first reported a position in VYGR in Q4 2016 and has held it in 32 quarters since. The position peaked at $2.48M in Q1 2023. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.
- Jeff Yass held 90,899 shares of Voyager Therapeutics worth $318K as of Q2 2026.
- Jeff Yass bought 12,008 Voyager Therapeutics shares in Q2 2026, an estimated $45.5K.
- Voyager Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10912 holding.
- Jeff Yass first reported a position in Voyager Therapeutics in Q4 2016 and has held it in 32 quarters since.
- Jeff Yass's Voyager Therapeutics position peaked at $2.48M in Q1 2023.
- 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.